News

AstraZeneca announced that the EC green-lighted the new formulation of the once-weekly type-2 diabetes injection, which will be marketed as Bydureon BCise (exenatide 2mg prolonged-release suspension).
Whether you have a diagnosis or are curious about your options, this guide answers some of the most common questions about injectable medications for type 2 diabetes. Injectable medications ...
A mediterranean diet and regular exercise can combat age-related bone mineral density loss in older women with metabolic syndrome, new evidence has demonstrated. Researchers have found that a ...
People who follow a fatty, sugary diet are more likely to experience cognitive complications compared to those following diets low in fat and sugar, new research has shown. A recent study from the ...
Data Sources: PubMed was searched (to December 5, 2011) using the terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and conducted ...
Expert Rev Endocrinol Metab. 2013;8(3):247-259. It is unclear to what degree these specific changes in CV parameters and risk factors play in overall clinical outcomes. As earlier outlined, short ...
Two-year data from a phase 3 trial of exenatide in Parkinson’s is due later this year and could help answer that question, said Prof Foltynie.
Their study showed that using two diabetes medications together—dapagliflozin and exenatide—can provide better results for people whose diabetes is not well controlled with metformin alone.
These two drugs are dapagliflozin and exenatide. When used together, they not only control blood sugar better than using just one extra drug but also keep working well over a long period of time.
1. The Critical-Care Pain Observation Tool (CPOT) showed strong correlations with other validated pain observation tools in pediatric patients The Critical-Care Pain Observation Tool (CPOT), a ...
On April 28, 2005, the type 2 diabetes medication exenatide became the first glucagon-like–peptide (GLP)-1 receptor agonist to earn FDA approval. Nearly 20 years to the day, on April 27, Daniel ...